Abu Dhabi health chief kicks off Phase 3 Covid-19 vaccine trials in UAE

 khaleejtimes.com  07/16/2020 22:01:00  4  Karen Ann Monsy
Abu Dhabi health chief, Covid-19 vaccine, UAE coronavirus , Covid-19, China, warning, Coronavirus outbreak, lockdown, pandemic, Dubai, new cases, Covid-19 death, recoveries

The world's first WHO-listed Phase III clinical trial of the Covid-19 inactivated vaccine has begun in Abu Dhabi, with Sheikh Abdullah bin Mohammed Al Hamed, Chairman of the Department of Health - Abu Dhabi, the first to participate in the trial.

He will be followed by Acting Undersecretary Dr. Jamal Al Kaabi, highlighting Abu Dhabi's commitment to finding a global cure.

??? ???? ?? ???? ?? ????? ???? ????? ????? ???????? ??? ????? ????? ?? ??????? ???????? ???? ???? ?? #?????? ??????? ??????? ?? ?????? ??? ????? ????? ?????-19? ???? ??????? ???? ??????? ???? ????? ????? ????????? ??? ????? ???? ???? ?????? ??????? ?????? ???? ????? ??????. pic.twitter.com/TX6AJPxJh3

- ???? ?????? ???????? (@admediaoffice) July 16, 2020

The trial is a collaboration between Abu Dhabi-based company G42 Healthcare and Chinese pharmaceutical group Sinopharm under the administration of the Department of Health and the Ministry of Health.

It was inspired by the UAE leadership's vision to overcome the pandemic through a global collaborative effort.

The world's first @WHO-listed phase III clinical trial of the Covid-19 inactivated vaccine has begun in #AbuDhabi, with @DoHSocial Chairman, Sheikh Abdullah bin Mohammed Al Hamed the 1st to participate in the trial, followed by Acting Undersecretary Dr. Jamal Al Kaabi. pic.twitter.com/gEIFgcSFHC

- ???? ?????? ???????? (@admediaoffice) July 16, 2020

The aim of the partnership is to help provide quick access to the vaccine for UAE residents, with manufacturing taking place in Abu Dhabi.

Phase III trials will be open to individual volunteers aged between 18 and 60, and living in Abu Dhabi or Al Ain. The trials will last for 3-6 months.

They follow the success of the Phase I and Phase II trials conducted in China, which resulted in 100 per cent of volunteers generating antibodies after two doses in 28 days.

The UAE was the preferred choice for Phase III trials owing to the diverse population of 200+ nationalities. This allows for research across multiple ethnicities, thereby increasing its feasibility for global application eventually.

« Go back

Top news today

Right-wing extremists and their supporters use Christian website to raise funds 01/20/2021 03:05:09
Why did The CW skyrocket to the top of the App Store? 01/19/2021 21:57:11
Samsung 870 EVO SATA SSD review: The speed you need, at sane prices 01/19/2021 15:00:00
Biden and Harris mourn 400,000 US lives lost to Covid-19 after arriving in Washington 01/01/2021 00:00:00
Variant might partially evade protection from vaccines or prior infection, early research suggests 01/20/2021 03:35:18
99 million-year-old beetle shines light on the evolution of glowing insects 01/20/2021 00:01:06
Biden's somber tone provides striking contrast with a year of Trump denials 01/20/2021 00:04:28
Ex-Guantanamo chief prosecutor calls for ‘DOMESTIC WAR ON SEDITION,’ suggests GOP congressman more guilty than Gitmo detainees 01/19/2021 22:38:17
Civil rights leaders hope Biden can heal the nation through action 01/20/2021 00:38:06
HDFury 4K Arcana review: This magic box fixes a crucial shortcoming of pre-2019 TVs 01/19/2021 11:00:00
Fauci says it 'has not been an easy thing' to have to contradict Trump on scientific facts 01/01/2021 00:00:00
Qualcomm's Snapdragon 870 is a faster 865, but without WiFi 6E 01/19/2021 14:30:00
Trump tells people he's decided to pardon Bannon as one of his final acts in office 01/19/2021 13:15:29
Trump offers 'best wishes' to new administration in farewell video address 01/01/2021 00:00:00
Biden prepares for inauguration on Trump's last full day in office 01/01/2021 00:00:00